EPISODE · May 9, 2026 · 4 MIN
今天3分钟我们来聊聊葡萄膜炎新疗法：干细胞带来光明
from 源于细胞BioInsid的个人播客
葡萄膜炎是致盲性眼病，传统激素治疗副作用大。全球首例干细胞治疗临床报道显示，4名患者中3人视力显著改善，最高提升20倍，3人停药无复发，为患者带来新希望。参考资料Human umbilical cord mesenchymal stem cell therapy for uveitis: the first clinical case report. International Journal of Ophthalmology.全球首例人脐带间充质干细胞治疗葡萄膜炎临床报道核心数据备忘葡萄膜炎年新发病率：50/10万人葡萄膜炎患病率：>700/10万人致盲占比：全球失明的5-10%治疗患者：4例视力显著改善：3例，最高提升20倍停药无复发：3例最长随访：3年MSC剂量：1×10⁶/kg细胞前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊葡萄膜炎新疗法：干细胞带来光明
0:00
4:33
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 4 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on May 9, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!